Scopolamine for the treatment of depression and anxiety

Details for Australian Patent Application No. 2006251893 (hide)

Owner The Government of The United States of America, as represented by The Secretary Department of Health and Human Services National Institutes of Health

Inventors Furey, Maura L.; Drevets, Wayne C.

Agent FB Rice

Pub. Number AU-A-2006251893

PCT Pub. Number WO2006/127418

Priority 11/137,114 25.05.05 US

Filing date 18 May 2006

Wipo publication date 30 November 2006

International Classifications

A61K 31/46 (2006.01) - 8-Azabicyclo [3.2.1] octane

A61K 9/12 (2006.01) Medicinal preparations characterised by special physical form - Aerosols

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

Event Publications

3 January 2008 PCT application entered the National Phase

  PCT publication WO2006/127418 Priority application(s): WO2006/127418

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006251899-Methods for promoting health or wellness in adult animals

2006251889-System for determininig availability of a tradable instrument